Home Adaptimmune IPO Well Received By Wall Street With Plenty Of Upside Left
 

Keywords :   


Adaptimmune IPO Well Received By Wall Street With Plenty Of Upside Left

2015-05-09 12:27:58| Biotech - Topix.net

Adaptimmune Therapeutics made its initial public offering on May 6 for $17 per share. The company is a clinical trial stage biotech researching immunotherapies that use T-cell platform technology.

Tags: left street received wall

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Mortgage rates hitting affordability - Nationwide
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 10A
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Tropical Storm Chris Graphics
01.07Tropical Storm Chris Public Advisory Number 2A
01.07Atlantic Tropical Weather Outlook
01.07Eastern North Pacific Tropical Weather Outlook
More »